G - Physics – 01 – N
Patent
G - Physics
01
N
G01N 33/68 (2006.01)
Patent
CA 2373150
The present invention is directed to a method of diagnosing Alzheimer's disease involving analysis of a plasma or serum sample in such a way that .beta.-amyloid1-42 or A.beta.3pE is completely or nearly completely (ie., thoroughly) dissociated from binding proteins prior to the analysis of the levels of .beta.-amyloid1-42 or A.beta.3pE.
La présente invention porte sur un procédé de diagnostic de la maladie d'Alzheimer, ce procédé consistant à analyser un échantillon de plasma ou de sérum de telle façon que .beta.-amyloid¿1-42? ou A.beta.3pE soit totalement ou quasi totalement (à savoir, parfaitement) dissocié des protéines de liaison avant l'analyse des taux de .beta.-amyloid¿1-42? ou A.beta.3pE.
Dawkes Adrian
Plata Salaman Carlos R.
Reitz Allen B.
Wang Haou-Yan
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
Ortho-Mcneil Pharmaceutical Inc.
LandOfFree
Method for diagnosis of alzheimer's disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for diagnosis of alzheimer's disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for diagnosis of alzheimer's disease will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1545267